Letrazuril

Letrazuril

SCHEMBL7180358

Cc1ncc([N+](=O)[O-])n1CCO.N#CC(c1ccc(F)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
NR1I2 O75469 1/20 0.56
ALDH1A1 P00352 4/20 0.43
THRB P10828 3/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
THRA P10827 2/20 0.38
GUSB P08236 1/20 0.38
EGFR P00533 4/20 0.37
ERBB2 P04626 4/20 0.37
TYMS P04818 2/20 0.37
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Letrazuril SCHEMBL466345 0.81 MEN1 (0.83) MEN1KMT2ANR1I2ALDH1A1THRB
SCHEMBL10420836 0.78 MEN1 (0.72) MEN1KMT2ANR1I2ALDH1A1THRB
SCHEMBL10421447 0.74 MEN1 (0.65) MEN1KMT2ANR1I2ALDH1A1THRB
SCHEMBL9823618 0.74 MEN1 (0.83) MEN1KMT2ANR1I2ALDH1A1THRB
Diclazuril SCHEMBL126138 0.73 MEN1 (1.00) MEN1KMT2ANR1I2THRBTHRA
SCHEMBL10403617 0.71 KMT2A (0.78) MEN1KMT2ANR1I2ALDH1A1THRB
SCHEMBL10671723 0.71 MEN1 (0.66) MEN1KMT2ANR1I2ALDH1A1THRB
SCHEMBL7919703 0.71 MEN1 (0.86) MEN1KMT2ANR1I2THRBTHRA
SCHEMBL10420205 0.69 MEN1 (0.82) MEN1KMT2ANR1I2ALDH1A1THRB
SCHEMBL10675273 0.68 MEN1 (0.58) MEN1KMT2ANR1I2THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1302468-A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 2003-04-16 EP disclosed